Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 2/2011

01-04-2011 | Case Report

Asymptomatic curable pancreatic ductal carcinoma detected during the follow-up of pancreatic cysts distinct from carcinoma

Authors: Natsuko Kawada, Hiroyuki Uehara, Kazuhiro Katayama, Sachiko Tanaka, Rena Takakura, Yasuna Takano, Tatsuya Ioka, Miho Nakao, Kazuho Imanaka, Kazuyoshi Ohkawa, Akemi Takenaka, Yasuhiko Tomita, Osamu Ishikawa

Published in: Clinical Journal of Gastroenterology | Issue 2/2011

Login to get access

Abstract

Recent studies have reported that pancreatic ductal carcinomas are frequently found during the follow-up of pancreatic cysts distinct from carcinoma; however, the majority of them are detected in advanced stages. Therefore, the early detection of metachronous ductal carcinomas is one of the issues in the management of pancreatic cysts. A 25-mm pancreatic cyst in the pancreatic head was found during an annual check-up in a 70-year-old woman. She was followed up every 6 months by abdominal ultrasound (US) and blood tests, and every 12 months by an additional magnetic resonance imaging scan. Twelve months later, abdominal US revealed a suspicious low-echoic area of 17 mm diameter in the pancreatic body. Eighteen months later, her serum carbohydrate antigen 19-9 level rose to 92 U/ml. Endoscopic retrograde pancreatography demonstrated a strictured main pancreatic duct (MPD) of 15 mm in length in the pancreatic body. A cytological examination of the brushed MPD revealed adenocarcinoma. The patient underwent distal pancreatectomy and splenectomy after chemoradiotherapy. An histological examination revealed a ductal carcinoma of 26 mm diameter in the pancreatic body, which was successfully resected. This case might help to establish an optimal surveillance method to detect metachronous ductal carcinomas arising from the pancreas harboring cystic lesions.
Literature
1.
go back to reference Jemel A, Siegel R, Xu J, Ward E. Cancer statistics. CA Cancer J Clin. 2010;60(5):277–300.CrossRef Jemel A, Siegel R, Xu J, Ward E. Cancer statistics. CA Cancer J Clin. 2010;60(5):277–300.CrossRef
2.
go back to reference Pancreatic Cancer Registration Committee of Japan Pancreas Society. Annual report of national registration of pancreatic cancer patients in 20 years from 1981 to 2000 (in Japanese). J Jpn Panc Soc. 2003;18:101–69. Pancreatic Cancer Registration Committee of Japan Pancreas Society. Annual report of national registration of pancreatic cancer patients in 20 years from 1981 to 2000 (in Japanese). J Jpn Panc Soc. 2003;18:101–69.
3.
go back to reference Uehara H, Nakaizumi A, Ishikawa O, Iishi H, Tatsumi K, Takakura R, et al. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Gut. 2008;57:1561–5.PubMedCrossRef Uehara H, Nakaizumi A, Ishikawa O, Iishi H, Tatsumi K, Takakura R, et al. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Gut. 2008;57:1561–5.PubMedCrossRef
4.
go back to reference Tada M, Kawabe T, Arizumi M, Togawa O, Matsubara S, Yamamoto N, et al. Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients. Clin Gastroenterol Hepatol. 2006;4:1265–70.PubMedCrossRef Tada M, Kawabe T, Arizumi M, Togawa O, Matsubara S, Yamamoto N, et al. Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients. Clin Gastroenterol Hepatol. 2006;4:1265–70.PubMedCrossRef
5.
go back to reference Tanno S, Nakano Y, Sugiyama Y, Nakamura K, Sasajima J, Koizumi K, et al. Incidence of synchronous and metachronous pancreatic carcinoma in 168 patients with branch duct intraductal papillary mucinous neoplasm. Pancreatology. 2010;10:173–8.PubMedCrossRef Tanno S, Nakano Y, Sugiyama Y, Nakamura K, Sasajima J, Koizumi K, et al. Incidence of synchronous and metachronous pancreatic carcinoma in 168 patients with branch duct intraductal papillary mucinous neoplasm. Pancreatology. 2010;10:173–8.PubMedCrossRef
6.
go back to reference Ingkakul T, Sadakari Y, Ienaga J, Satoh N, Takahata S, Tanaka M. Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas. Ann Surg. 2010;251:70–5.PubMedCrossRef Ingkakul T, Sadakari Y, Ienaga J, Satoh N, Takahata S, Tanaka M. Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas. Ann Surg. 2010;251:70–5.PubMedCrossRef
7.
go back to reference Allen PJ, D’Angelica M, Gonen M, Jaques DP, Coit DG, Jarnagin WR, et al. A selective approach to the resection of cystic lesions of the pancreas. Results from 539 consecutive patients. Ann Surg. 2006;244:572–82.PubMed Allen PJ, D’Angelica M, Gonen M, Jaques DP, Coit DG, Jarnagin WR, et al. A selective approach to the resection of cystic lesions of the pancreas. Results from 539 consecutive patients. Ann Surg. 2006;244:572–82.PubMed
8.
go back to reference Kamisawa T, Tu Y, Egawa N, Nakajima H, Tsuruta K, Okamoto A. Malignancies associated with intraductal papillary mucinous neoplasm of the pancreas. World J Gastroenterol. 2005;11(36):5688–90.PubMed Kamisawa T, Tu Y, Egawa N, Nakajima H, Tsuruta K, Okamoto A. Malignancies associated with intraductal papillary mucinous neoplasm of the pancreas. World J Gastroenterol. 2005;11(36):5688–90.PubMed
9.
go back to reference Sohn TA, Yeo CJ, Cameron JL, Hurban RH, Fukushima N, Campbell KA, et al. Intraductal papillary mucinous neoplasm of the pancreas. An updated experience. Ann Surg. 2004;239:788–99.PubMedCrossRef Sohn TA, Yeo CJ, Cameron JL, Hurban RH, Fukushima N, Campbell KA, et al. Intraductal papillary mucinous neoplasm of the pancreas. An updated experience. Ann Surg. 2004;239:788–99.PubMedCrossRef
10.
go back to reference Yamaguchi K, Ohuchida J, Ohtsuka T, Nakano K, Tanaka M, et al. Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas. Pancreatology. 2002;2:484–90.PubMedCrossRef Yamaguchi K, Ohuchida J, Ohtsuka T, Nakano K, Tanaka M, et al. Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas. Pancreatology. 2002;2:484–90.PubMedCrossRef
11.
go back to reference Sakamoto H, Kitano M, Komaki T, Imai H, Kamata K, Kimura M, et al. Small invasive ductal carcinoma of the pancreas distinct from branch duct intraductal papillary mucinous neoplasm. World J Gastroenterol. 2009;15(43):5489–92.PubMedCrossRef Sakamoto H, Kitano M, Komaki T, Imai H, Kamata K, Kimura M, et al. Small invasive ductal carcinoma of the pancreas distinct from branch duct intraductal papillary mucinous neoplasm. World J Gastroenterol. 2009;15(43):5489–92.PubMedCrossRef
12.
go back to reference Komori T, Ishikawa O, Ohigashi H, Yamada T, Sasaki Y, Imaoka S, et al. Invasive ductal adenocarcinoma of the remnant pancreatic body 9 years after resection of an intraductal papillary-mucinous carcinoma of the pancreatic head: a case report and comparison of DNA sequence in K-ras gene mutation. Jpn J Clin Oncol. 2002;32(4):146–51.PubMedCrossRef Komori T, Ishikawa O, Ohigashi H, Yamada T, Sasaki Y, Imaoka S, et al. Invasive ductal adenocarcinoma of the remnant pancreatic body 9 years after resection of an intraductal papillary-mucinous carcinoma of the pancreatic head: a case report and comparison of DNA sequence in K-ras gene mutation. Jpn J Clin Oncol. 2002;32(4):146–51.PubMedCrossRef
13.
go back to reference Yamaguchi K, Nakamura K, Yokohata K, Shimizu S, Chijiwa K, Tanaka M. Pancreatic cyst as a sentinel of in situ carcinoma of the pancreas. Int J Pancreatol. 1997;22(3):227–31.PubMed Yamaguchi K, Nakamura K, Yokohata K, Shimizu S, Chijiwa K, Tanaka M. Pancreatic cyst as a sentinel of in situ carcinoma of the pancreas. Int J Pancreatol. 1997;22(3):227–31.PubMed
14.
go back to reference Tanaka S, Nakao M, Ioka T, Takakura R, Takano Y, Tsukuma H, et al. Slight dilatation of the main pancreatic duct and presence of pancreatic cysts as predictive signs of pancreatic cancer: a prospective study. Radiology. 2010;254(3):965–72.PubMedCrossRef Tanaka S, Nakao M, Ioka T, Takakura R, Takano Y, Tsukuma H, et al. Slight dilatation of the main pancreatic duct and presence of pancreatic cysts as predictive signs of pancreatic cancer: a prospective study. Radiology. 2010;254(3):965–72.PubMedCrossRef
15.
go back to reference Sobin L, Gospodarowicz M, Wittekind C. UICC International union against cancer. TNM classification of malignant tumours. 7th ed. UK: Wiley-Blackwell; 2009. Sobin L, Gospodarowicz M, Wittekind C. UICC International union against cancer. TNM classification of malignant tumours. 7th ed. UK: Wiley-Blackwell; 2009.
16.
go back to reference Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms of the pancreas. Pancreatology. 2006;6:17–32.PubMedCrossRef Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms of the pancreas. Pancreatology. 2006;6:17–32.PubMedCrossRef
17.
go back to reference Fernandez-del Castillo CF, Targarona J, Thayer SP, et al. Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg. 2003;138:427–34.PubMedCrossRef Fernandez-del Castillo CF, Targarona J, Thayer SP, et al. Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg. 2003;138:427–34.PubMedCrossRef
18.
go back to reference Kloeppel G, Kosmahl M. Cystic lesions and neoplasms of the pancreas. The features are becoming clearer. Pancreatology. 2001;1:648–55.CrossRef Kloeppel G, Kosmahl M. Cystic lesions and neoplasms of the pancreas. The features are becoming clearer. Pancreatology. 2001;1:648–55.CrossRef
19.
go back to reference Tateishi K, Tada M, Yamagata M, Isayama H, Komatsu Y, Kawabe T, et al. High proportion of mutant K-ras gene in pancreatic juice of patients with pancreatic cystic lesions. Gut. 1999;45:737–40.PubMedCrossRef Tateishi K, Tada M, Yamagata M, Isayama H, Komatsu Y, Kawabe T, et al. High proportion of mutant K-ras gene in pancreatic juice of patients with pancreatic cystic lesions. Gut. 1999;45:737–40.PubMedCrossRef
20.
go back to reference Tada M, Tateishi K, Kawabe T, Sasahira N, Isayama H, Komatsu Y, et al. Quality of mutant K-ras gene in pancreatic juice of patients with pancreatic carcinoma with different assays: analysis of 100 patients. Clin Chim Acta. 2002;324:105–11.PubMedCrossRef Tada M, Tateishi K, Kawabe T, Sasahira N, Isayama H, Komatsu Y, et al. Quality of mutant K-ras gene in pancreatic juice of patients with pancreatic carcinoma with different assays: analysis of 100 patients. Clin Chim Acta. 2002;324:105–11.PubMedCrossRef
21.
go back to reference Ohigashi H, Ishikawa O, Eguchi H, Takahashi H, Gotoh K, Yamada T, et al. Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer. Ann Surg. 2009;250(1):88–95.PubMedCrossRef Ohigashi H, Ishikawa O, Eguchi H, Takahashi H, Gotoh K, Yamada T, et al. Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer. Ann Surg. 2009;250(1):88–95.PubMedCrossRef
Metadata
Title
Asymptomatic curable pancreatic ductal carcinoma detected during the follow-up of pancreatic cysts distinct from carcinoma
Authors
Natsuko Kawada
Hiroyuki Uehara
Kazuhiro Katayama
Sachiko Tanaka
Rena Takakura
Yasuna Takano
Tatsuya Ioka
Miho Nakao
Kazuho Imanaka
Kazuyoshi Ohkawa
Akemi Takenaka
Yasuhiko Tomita
Osamu Ishikawa
Publication date
01-04-2011
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 2/2011
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-011-0210-4

Other articles of this Issue 2/2011

Clinical Journal of Gastroenterology 2/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.